Oral prolonged-release ketamine formulation (KET01) demonstrates minimal dissociation and cardiovascular effects with early antidepressant ...
The deal comes about three months after President Donald Trump signed an executive order directing the U.S. Food and Drug Administration and other federal agencies to speed research and loosen ...
Calgary, Alberta--(Newsfile Corp. - February 18, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), is pleased to announce that it is receiving advisory services and funding from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results